KR102907590B1 - 동적 인간 중쇄 항체 라이브러리 - Google Patents
동적 인간 중쇄 항체 라이브러리Info
- Publication number
- KR102907590B1 KR102907590B1 KR1020247022149A KR20247022149A KR102907590B1 KR 102907590 B1 KR102907590 B1 KR 102907590B1 KR 1020247022149 A KR1020247022149 A KR 1020247022149A KR 20247022149 A KR20247022149 A KR 20247022149A KR 102907590 B1 KR102907590 B1 KR 102907590B1
- Authority
- KR
- South Korea
- Prior art keywords
- hvr
- amino acid
- acid sequence
- seq
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/04—Methods of creating libraries, e.g. combinatorial synthesis using dynamic combinatorial chemistry techniques
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020207007876A KR20200038996A (ko) | 2017-08-21 | 2017-08-21 | 동적 인간 중쇄 항체 라이브러리 |
| PCT/CN2017/098299 WO2019036842A1 (en) | 2017-08-21 | 2017-08-21 | DYNAMIC LIBRARIES OF HUMAN HEAVY CHAIN ANTIBODIES |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207007876A Division KR20200038996A (ko) | 2017-08-21 | 2017-08-21 | 동적 인간 중쇄 항체 라이브러리 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20240110891A KR20240110891A (ko) | 2024-07-16 |
| KR102907590B1 true KR102907590B1 (ko) | 2026-01-05 |
Family
ID=65438261
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247022149A Active KR102907590B1 (ko) | 2017-08-21 | 2017-08-21 | 동적 인간 중쇄 항체 라이브러리 |
| KR1020207007876A Ceased KR20200038996A (ko) | 2017-08-21 | 2017-08-21 | 동적 인간 중쇄 항체 라이브러리 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207007876A Ceased KR20200038996A (ko) | 2017-08-21 | 2017-08-21 | 동적 인간 중쇄 항체 라이브러리 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11578426B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3673101A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2020537632A (cg-RX-API-DMAC7.html) |
| KR (2) | KR102907590B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111279024B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017428737B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020003622A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3072143A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL272696B2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202001551YA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019036842A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202001114B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202001549UA (en) | 2017-08-21 | 2020-03-30 | Adagene Inc | Dynamic human antibody light chain libraries |
| CN111511762B (zh) | 2017-08-21 | 2025-05-06 | 天演药业公司 | 抗cd137分子及其用途 |
| AU2017428737B2 (en) | 2017-08-21 | 2024-02-15 | Adagene Inc. | Dynamic human heavy chain antibody libraries |
| WO2019148444A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Anti-ctla4 antibodies and methods of making and using the same |
| WO2019148445A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
| CN114835811B (zh) * | 2019-12-24 | 2024-03-26 | 宝船生物医药科技(上海)有限公司 | 抗csf1r分子及其用途 |
| US11834512B2 (en) | 2020-05-04 | 2023-12-05 | The Regents Of The University Of California | Inhibiting anti-ENPP1 antibodies |
| EP4225786A2 (en) * | 2020-10-07 | 2023-08-16 | Amgen Inc. | Rational selection of building blocks for the assembly of multispecific antibodies |
| WO2023193239A1 (en) * | 2022-04-08 | 2023-10-12 | Peter Peizhi Luo | Anti-cd28 antibodies and methods of use thereof |
| KR20260026665A (ko) | 2024-08-20 | 2026-02-27 | 엘지디스플레이 주식회사 | 표시 장치 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013534130A (ja) * | 2010-07-16 | 2013-09-02 | アディマブ, エルエルシー | 抗体ライブラリー |
| WO2016062989A1 (en) * | 2014-10-22 | 2016-04-28 | Crescendo Biologics Limited | Human vh domain scaffolds |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| DE4002897A1 (de) * | 1990-02-01 | 1991-08-08 | Behringwerke Ag | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| EP0604580A1 (en) | 1991-09-19 | 1994-07-06 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US20030036092A1 (en) | 1991-11-15 | 2003-02-20 | Board Of Regents, The University Of Texas System | Directed evolution of enzymes and antibodies |
| US5866344A (en) | 1991-11-15 | 1999-02-02 | Board Of Regents, The University Of Texas System | Antibody selection methods using cell surface expressed libraries |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| CA2219361C (en) | 1995-04-27 | 2012-02-28 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP1972194A1 (en) | 1996-12-03 | 2008-09-24 | Amgen Fremont Inc. | Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
| DE60224720D1 (en) | 2001-11-22 | 2008-03-06 | Univ Keio | Re |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| CA2608058C (en) | 2005-05-12 | 2013-09-10 | Crucell Holland B.V. | Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| EP1957531B1 (en) | 2005-11-07 | 2016-04-13 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| JP5425180B2 (ja) | 2008-03-27 | 2014-02-26 | ザイモジェネティクス, インコーポレイテッド | PDGFRβおよびVEGF−Aを阻害するための組成物および方法 |
| WO2012023053A2 (en) | 2010-08-16 | 2012-02-23 | Novimmune S.A. | Methods for the generation of multispecific and multivalent antibodies |
| CN105247050B (zh) | 2013-03-14 | 2020-06-16 | 天演药业 | 用于文库构建、亲和力结合剂筛选和其表达的整合系统 |
| CN103603057B (zh) | 2013-07-03 | 2016-01-06 | 深圳大学 | 基于可感染病毒颗粒型抗体重链库/轻链库的抗体筛选和制备方法 |
| EP4477269A3 (en) | 2015-09-20 | 2025-03-19 | The United States of America, as Represented By the Secretary, Department of Health and Human Services | Monoclonal antibodies specific for fibroblast growth factor receptor 4 (fgfr4) and methods of their use |
| AU2017428737B2 (en) | 2017-08-21 | 2024-02-15 | Adagene Inc. | Dynamic human heavy chain antibody libraries |
| SG11202001549UA (en) | 2017-08-21 | 2020-03-30 | Adagene Inc | Dynamic human antibody light chain libraries |
-
2017
- 2017-08-21 AU AU2017428737A patent/AU2017428737B2/en active Active
- 2017-08-21 BR BR112020003622-6A patent/BR112020003622A2/pt unknown
- 2017-08-21 EP EP17922682.4A patent/EP3673101A4/en active Pending
- 2017-08-21 SG SG11202001551YA patent/SG11202001551YA/en unknown
- 2017-08-21 IL IL272696A patent/IL272696B2/en unknown
- 2017-08-21 CN CN201780094151.XA patent/CN111279024B/zh active Active
- 2017-08-21 US US16/640,679 patent/US11578426B2/en active Active
- 2017-08-21 KR KR1020247022149A patent/KR102907590B1/ko active Active
- 2017-08-21 KR KR1020207007876A patent/KR20200038996A/ko not_active Ceased
- 2017-08-21 JP JP2020510115A patent/JP2020537632A/ja active Pending
- 2017-08-21 CA CA3072143A patent/CA3072143A1/en active Pending
- 2017-08-21 WO PCT/CN2017/098299 patent/WO2019036842A1/en not_active Ceased
-
2020
- 2020-02-21 ZA ZA2020/01114A patent/ZA202001114B/en unknown
-
2022
- 2022-11-10 JP JP2022180076A patent/JP2023025026A/ja not_active Withdrawn
-
2023
- 2023-01-11 US US18/153,070 patent/US12385162B2/en active Active
-
2024
- 2024-09-20 JP JP2024163531A patent/JP7856719B2/ja active Active
-
2025
- 2025-06-25 US US19/249,863 patent/US20260146368A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013534130A (ja) * | 2010-07-16 | 2013-09-02 | アディマブ, エルエルシー | 抗体ライブラリー |
| WO2016062989A1 (en) * | 2014-10-22 | 2016-04-28 | Crescendo Biologics Limited | Human vh domain scaffolds |
Non-Patent Citations (2)
| Title |
|---|
| Chingwei V. Lee et al., ‘High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework Scaffold’, J. Mol. Biol, Vol. 340, pp. 1073-1093, 2004.* |
| Sachdev S. Sidhu et al., ‘Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions’, J. Mol. Biol., Vol. 338, pp. 299-310, 2004.* |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024178314A (ja) | 2024-12-24 |
| NZ761783A (en) | 2025-11-28 |
| IL272696B1 (en) | 2024-09-01 |
| ZA202001114B (en) | 2024-06-26 |
| SG11202001551YA (en) | 2020-03-30 |
| KR20240110891A (ko) | 2024-07-16 |
| JP7856719B2 (ja) | 2026-05-11 |
| JP2023025026A (ja) | 2023-02-21 |
| US11578426B2 (en) | 2023-02-14 |
| US12385162B2 (en) | 2025-08-12 |
| EP3673101A1 (en) | 2020-07-01 |
| AU2017428737B2 (en) | 2024-02-15 |
| US20200248336A1 (en) | 2020-08-06 |
| IL272696A (en) | 2020-04-30 |
| EP3673101A4 (en) | 2021-03-24 |
| CN111279024B (zh) | 2024-07-19 |
| JP2020537632A (ja) | 2020-12-24 |
| AU2017428737A8 (en) | 2020-03-12 |
| US20260146368A1 (en) | 2026-05-28 |
| US20240240358A1 (en) | 2024-07-18 |
| WO2019036842A1 (en) | 2019-02-28 |
| AU2017428737A1 (en) | 2020-03-05 |
| CN111279024A (zh) | 2020-06-12 |
| BR112020003622A2 (pt) | 2020-09-01 |
| IL272696B2 (en) | 2025-01-01 |
| KR20200038996A (ko) | 2020-04-14 |
| CA3072143A1 (en) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7856719B2 (ja) | ダイナミックヒト重鎖抗体ライブラリー | |
| US20230287597A1 (en) | Dynamic human antibody light chain libraries | |
| CA2572917C (en) | Look-through mutagenesis for developing altered polypeptides with enhanced properties | |
| US20190002558A1 (en) | Compositions and methods for the identification and isolation of cell-membrane protein specific binding moieties | |
| Vellalore Maruthachalam | NEXT-GENERATION SEQUENCING AND MOTIF GRAFTING APPLICATIONS IN SYNTHETIC ANTIBODY DISCOVERY | |
| Tiller | Synthetic Antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A18-div-PA0104 St.27 status event code: A-0-1-A10-A16-div-PA0104 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| F11 | Ip right granted following substantive examination |
Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| U12 | Designation fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| Q13 | Ip right document published |
Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE) |